BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04624204-completion@plaintrial.com
DTSTAMP:20261027T122943Z
DTSTART;VALUE=DATE:20271028
SUMMARY:Placebo-controlled\, Study of Concurrent Chemoradiation Therapy Wit
 h Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed 
 Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-0
 13/KEYLYNK-013) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04624204
URL:https://plaintrial.com/trial/NCT04624204
END:VEVENT
END:VCALENDAR